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Public healthA repeated measures microarray design with 22 healthy, non-smoking volunteers (aging 32 ± 5 years) was set
up to study transcriptome proﬁles in whole blood samples. The results indicate that repeatable data can be
obtainedwith highwithin-subject correlation. Probes that could discriminate between individuals are associated
with immune and inﬂammatory functions. When investigating possible time trends in the microarray data, we
have found no differential expression within a sampling period (within-season effect). Differential expression
was observed between sampling seasons and the data suggest a weak response of genes related to immune
system functioning. Finally, a high number of probes showed signiﬁcant season-speciﬁc expression variability
within subjects. Expression variability increased in springtime and there was an association of the probe list
with immune system functioning. Our study suggests that the blood transcriptome of healthy individuals is
reproducible over a time period of several months.
© 2013 Elsevier Inc. All rights reserved.1. Introduction
Genome-wide interrogation of transcript abundance in peripheral
blood cells is widely used to explore differences between diseased and
healthy individuals, deﬁne disease stage, monitor a therapy and phar-
macodynamic responses to a drug, or deﬁne prognosis [1]. Exposure to
environmental stressors and toxicants may also disturb an individual's
homeostasis, which may be reﬂected in gene expression changes in pe-
ripheral blood. This principle has been shown to hold true for study pop-
ulations exposed to persistent organic pollutants [2], heavy metals [3],
and complex mixtures such as cigarette smoke [4], diesel exhaust [5]
and air pollution [6]. Furthermore, analysis of altered gene expression
proﬁlesmay identify biological pathways that underlie the development
of common diseases [7,8]. It is envisioned that microarray technology
can become a useful tool for assessing the health impact of stressors inchnological Research (VITO),
asmeer 7, 2400 Mol, Belgium.
r).
ghts reserved.the context of occupational and environmental exposure to chemicals
and physical particles [9].
Technical aspects related to gene expression analysis have been stan-
dardized and the contribution to gene expression variability has been
characterized [10,11]. However, many factors contributing to biological
variability are less well documented. For example, temporal changes in
gene expression, within- and between-subject variability and lifestyle
characteristics (such as diet and smoking status) can inﬂuence the
outcome of gene expression studies [12].
In this study we report on the short‐ and long‐term gene expression
changes in whole blood samples of non-diseased adult individuals, as
well as intra- and inter-individual variation in gene expression. Therefore,
we have collected repeated measures over a period of six months using
gene expression microarrays.
2. Results
2.1. Population characteristics
The population characteristics are summarized in Table 1. 45% of
included participants were men. The population had a mean age of
Table 1
Details on the study participants and the outcome of the questionnaires that were
completed in conjunction with each blood sampling. Six blood samples were collected
for each person over a period of 6 months, resulting in a total set of 132 samples.
Study participants (n = 22)
Age (years) 32 ±5
Body Mass Index 23.1 ±2.5
Male (%) 45
Outcome of the 132 questionnaires (%)
Fasting at the moment of the examination 12
Self-reported health issue (week before the blood drawing) 14
Exposure to passive smoking during the past 24 h 11
Alcohol consumption (one glass or less)during the past 24 h 77
Coffee consumption (3 cups or less) during the past 24 h 71
Physical exercise during the past 24 h 22
Time spent in trafﬁc on the day of the examination (min)
In car 81
In congested trafﬁc 5
Biking or walking in trafﬁc 4
32 P. De Boever et al. / Genomics 103 (2014) 31–3932 ± 5 years and a mean body mass index of 23.1 ± 2.5. All partici-
pants had a university or college degree. Participants reported to be
healthy and without recent history of clinical disease. Twenty two vol-
unteers completed the study and this resulted in a total of 132 whole
blood samples, with 6 samples per individual. In 12% of the samples, in-
dividuals reported to be fasting. However, the prandial status was not
determined in the study. The questionnaires collected in parallel of
the blood sampling revealed 14% of self-reported health problems
(mostly cases of allergy) for which the individuals were taking standard
medication (antihistamines and bronchodilators). In 15% of the surveys,
individuals reported a health issue in theweek prior to the blood draw-
ing. Moderate coffee and alcohol consumption and average physical
activity was reported 24 h before the blood drawing.
2.2. Environmental conditions
Average outdoor temperature was not signiﬁcantly different
between the two sampling campaigns and the ambient concentrations
of chemical air pollutants were also comparable. The spring campaign
was characterized by signiﬁcantly higher pollen concentrations. The
results are summarized in Table 2.
2.3. Microarray data generation
All blood sampleswere submitted to RNA extraction and the average
RNA yield per sample was 8.44 ± 2.71 μg (n = 132). The quality of the
samples was checked after globin removal and RIN-values of
8.93 ± 0.40 (n = 132) were obtained.
Cy3-labeling resulted in an average speciﬁc activity of 16.73 ±
2.75 pmol/μg (n = 132). The samples were hybridized successfully
on 4X44K Agilent Whole Human Genome microarrays and all the
raw data ﬁles passed the default quality control metrics that areTable 2
Outdoor temperature and concentrations of ambient air pollutants that weremeasured in
the 2 sampling periods (season 1 and season 2) using ﬁxed measuring stations in the
neighborhood of the study site. Averages were calculated for both 3-week sampling
periods. Range of the measurements is also shown.
Season 1 Season 2
Temperature (°C) 9.9 ± 2.9 2.4–17.4 10.0 ± 4.9 2.6–28.1
Pollutants (μg/m3)
Particulate matter b 10 μm 18 3–62 20 3–81
NO 2 1–49 1 1–21
NO2 18 2–57 17 5–47
SO2 2 1–24 1 1–19
O3 39 1–76 57 1–131
Pollen (counts/m3)
Trees Not detected 127 ± 135 4–774
Plants Not detected 8 ± 2 1–22implemented in Feature Extraction. The median ± standard error of
the coefﬁcient of variation of the within-array repeated probes calculat-
ed for the 132 samples was 4.4 ± 1.1 %. This indicates a within-slide
technical variability of less than 5%. Data preprocessing resulted in a
ﬁnal set of 31,293 probes that was used for downstream analysis.2.4. Descriptive statistics
Pairwise Spearman correlations were high and all values exceeded
the threshold of 0.94. Fig. 1 summarizes the results in a heat map. The
microarray samples in Fig. 1 are sorted according to study participant
in order to group the 6 samples of each individual. The Spearman corre-
lations along the diagonal are the highest and this indicates that the
within-subject sample correlations were always higher than the
between-subject correlations.
Subsequently, the between/within sum of squares (BW) ratio across
the 22 individuals was determined for eachmicroarray probe. The anal-
ysis allowed identifying the probes that separate maximally between
the individuals. When ranking the BW ratios, a steep decrease in the
size of the BW ratios was observed for the ﬁrst 50 probes and ratios
leveled off at 250 probes (data not shown). These 250 probes and
their annotation are given in a supplementary Excel ﬁle (Supplementa-
ry ﬁle 1). The latter probe set was also used for hierarchical cluster anal-
ysis on the gene expression signals. The results revealed a perfect
clustering according to individual (Fig. 2). This conﬁrms the statement
about strong within-subject correlations that was based on the Spear-
man correlations. The discrimination between males and females
could be attributed to the expression signals of 8 probes. These probes
could be mapped to 7 genes located on the Y chromosome (KDM5D,
RPS4Y1, RPS4Y2, DDX3Y, EIF1AY, TMSB4Y and TTTY14).
Gene Ontology (GO) analysis of the 250 probes did not yield signiﬁ-
cantly enriched biological terms at a BH-FDR of 0.1. The signiﬁcantly
enriched canonical pathways (BH-FDR b 0.1) were autoimmune thy-
roid disease signaling, glutathione-mediated detoxiﬁcation and altered
T cell and B cell signaling in rheumatoid arthritis. The genes that were
contributing to this enrichmentweremainly related to antigen process-
ing and presentation (HLA-DQA1, HLA-DQB1, HLA-DRB1, HLA-DRB5
and MAPK8), inﬂammatory response (CCL3, CCL3L1, IL23A, NCR3,
PVRL2, PTPN22, FKBP1A and UTS2) and glutathione metabolism
(GSTM1, GSTM3, GSTM4 and GSTT1).Fig. 1. Heat map of pairwise Spearman correlations. The sample identiﬁers refer to the 22
study participants. The ﬁrst 10 numbers (3 to 21) refer to males, whereas the following
numbers (1 to 22) refer to females. The samples fromone individual are ordered according
to the time of sampling. The colors indicate the strength of the correlation, with dark red
indicating perfect correlation.
Fig. 2.Heatmap of 250 probeswith the largest between-within sumof squares ratio.Male samples are grouped together at the left side and female samples at the right side of the plot. The
cluster of 8 probes that could discriminate betweenmale and female samples is shown in red. The colors in the heatmap reﬂect the log2-signal intensity of the probe with the color range
going from green (low expression) to red (high expression value).
33P. De Boever et al. / Genomics 103 (2014) 31–39Finally, we analyzed the probes that were most variable among all
individuals. A cumulative distribution of the intra-individual coefﬁcient
of variation is plotted for the 22 individuals (Fig. 3). The plot shows that
the different distributions start to diverge at a proportion of 0.5. The 10%
most variable probes (proportion N 0.9) were identiﬁed for each indi-
vidual and the probes in common for all 22 individuals were selected.
This resulted in a set of 120 probes, of which 44 could be mapped to a
known gene symbol. NoGO terms or canonical pathwayswere enriched
in this gene list. Thirteen genes could be associated with cell death
(ANXA2, C9, GPR37 HNRNPA1, ICMT, IL8, MED29, QARS, RBBP6, SCD,
SET, SIRPA and XBP1). The complete list of 120 probes and their annota-
tion can be found in a supplementary Excel ﬁle (Supplementary ﬁle 2).Fig. 3. Cumulative distribution of the intra-individual coefﬁcients of variation plotted for
the 22 study participants. The coefﬁcient of variation was calculated for each probe
using 6 blood samples.2.5. Analysis of time trends
Short-term time (within-season) trends were evaluated for every
probe with a linear mixed-effects model (model 1). The analysis result-
ed in 110 probes thatwere called signiﬁcant (BH FDR b 0.05) in the ﬁrst
sampling period (season 1). No GO terms or canonical pathways were
enriched for this probe list. The probes and their annotation are listed
in a supplementary Excel ﬁle (Supplementary ﬁle 3). No probes were
changed in expression in the second sampling period (season 2).
The three biological samples within each period were considered as
repeated measures because of the limited short-term time effects.
Then,model 2was formulated to assess the effect of the ﬁxed factors
gender and sampling period (seasonal effect). Fitting ofmodel 2 learned
that therewere no probes called signiﬁcant for the season–gender inter-
action term. The interaction term was removed from the equation and
themodel was reﬁtted. A total number of 1995 probes were signiﬁcant-
ly (BH-FDR b 0.05) altered in expression for the ﬁxed effect season. The
probes and their annotation are given in a supplementary Excel ﬁle
(Supplementary ﬁle 4). GO analysis of these probes revealed that 10
terms were enriched (BH-FDR b 0.1) for the Biological Process branch,
14 for the Molecular Process branch and 17 terms for the Cellular Local-
ization (Table 3). The top-5 signaling pathways that were associated
with this dataset are rhoA signaling (21/115), actin cytoskeleton signal-
ing (29/230), ephrin receptor signaling (25/197), production of nitric
oxide and reactive oxygen species in macrophages (25/186) and NGF
signaling (17/111). The ratio between brackets indicates the number
of probes that were called differentially expressed over the total num-
ber of probes associatedwith that speciﬁc pathway. Only rhoA signaling
pathway was signiﬁcant at a BH-FDR b 0.1. In IPA, the gene list with
1995 probes was signiﬁcantly enriched for the bio function viral infec-
tion, with 177 probes associated with the latter function.
Subsequently, box plots were constructed to visualize the distribu-
tion of fold changes (average expression in season 2 over average ex-
pression in season 1) of the 1995 probes. This was done for each of
the 22 individuals (Fig. 4). The fold changes that were used to construct
Fig. 4 are given in a supplementary Excel ﬁle (Supplementary ﬁle 5).
Table 3
GeneOntology enrichment analysis performed on the probes thatwere called differentially expressed for the factor season in the linearmixed-effectsmodel (model 2). The signiﬁcance values
based on Benjamini–Hochberg multiplicity correction (BH-FDR) are given.
GO accession GO term BH-FDR
Biological process
GO:0044260|GO:0034960 Cellular macromolecule metabolic process 0.0267
GO:0006464 Cellular protein modiﬁcation process 0.0561
GO:0043412 Macromolecule modiﬁcation 0.0427
GO:0006397 mRNA processing 0.0530
GO:0006796 Phosphate-containing compound metabolic process 0.0350
GO:0006793 Phosphorus metabolic process 0.0350
GO:0036211 Protein modiﬁcation process 0.0561
GO:0043484 Regulation of RNA splicing 0.0573
GO:0006396|GO:0006394 RNA processing 0.0086
GO:0008380|GO:0006395 RNA splicing 0.0277
Cellular localization
GO:0005737 Cytoplasm 0.0079
GO:0005622 Intracellular 0.0000
GO:0043231 Intracellular membrane-bounded organelle 0.0062
GO:0043232 Intracellular non-membrane-bounded organelle 0.0350
GO:0043229 Intracellular organelle 0.0006
GO:0070013 Intracellular organelle lumen 0.0343
GO:0044424 Intracellular part 0.0000
GO:0043227 Membrane-bounded organelle 0.0062
GO:0031974 Membrane-enclosed lumen 0.0343
GO:0043228 Non-membrane-bounded organelle 0.0350
GO:0031981 Nuclear lumen 0.0217
GO:0044428 Nuclear part 0.0159
GO:0016607 Nuclear speck 0.0130
GO:0005730 Nucleolus 0.0547
GO:0005634 Nucleus 0.0238
GO:0043226 Organelle 0.0006
GO:0043233 Organelle lumen 0.0561
Molecular PROCESS
GO:0030554 Adenyl nucleotide binding 0.0029
GO:0032559 Adenyl ribonucleotide binding 0.0029
GO:0005524 ATP binding 0.0029
GO:0003824 Catalytic activity 0.0477
GO:0016301 Kinase activity 0.0343
GO:0000166 Nucleotide binding 0.0028
GO:0016773 Phosphotransferase activity, alcohol group as acceptor 0.0162
GO:0017076 Purine nucleotide binding 0.0148
GO:0035639 Purine ribonucleoside triphosphate binding 0.0159
GO:0032555 Purine ribonucleotide binding 0.0148
GO:0032553 Ribonucleotide binding 0.0148
GO:0036094 Small molecule binding 0.0075
GO:0016740 Transferase activity 0.0006
GO:0016772 Transferase activity, transferring phosphorus-containing groups 0.0028
34 P. De Boever et al. / Genomics 103 (2014) 31–39None of the probes showed a consistent up- or downregulation for all
individuals. The effect sizes were small and about 30% of the 1995
probes had absolute fold changes lower than 1.3 in all individuals.
Only 8 probes had absolute fold changes higher than 1.5 in at least 50%
of the individuals.
A total number of 191 probeswere called signiﬁcant (BH-FDR b 0.05)
for the ﬁxed effect gender. The probes and their annotation are given in a
supplementary Excel ﬁle (Supplementary ﬁle 4).
GO analysis and IPA analysis did not reveal any signiﬁcant enrich-
ment at the BH-FDR threshold of 0.1. Seventeen genes (ACBD4, APBB1,
CTC1, DDX3X, DDX3Y, DIS3, GCLM, KDM5D, MAPK1, MOB1A, NEK7,
PRKAR1A, SEPT6, SH2B1, TPM2, ZFX, ZFY) were in common
between the season and gender gene lists.
2.6. Analysis of gender- and season-speciﬁc variability
First, thehypothesiswas tested using likelihood ratio tests thatwith-
in- subject variability did not depend on gender and sampling period
(seasonal effect). This null hypothesis was rejected for a total of
10,057 probes (BH-FDR b 0.05). When the effect of gender and sam-
pling period were tested separately for the subset of 10,057 probes,
7533 probes rejected the hypothesis that within-subject variabilitywas independent of the factor gender and 8599 probes rejected the hy-
pothesis that within-subject variability was independent of sampling
period. Filtering of the 10,057 probes led to a subset of 4303 informative
probes that was used for further analysis. The coefﬁcients of variation of
the 4303probeswere visualized in density plots for the four experimen-
tal conditions (males and females in season 1 and males and females in
season 2). The plots for season 2 were shifted to the right when com-
pared to season 1, both for males (mauve plot versus green plot in
Fig. 5) and females (blue plot versus pink plot in Fig. 5). The top-1000
most signiﬁcant probes from the set of 4303probeswere selected for bi-
ological analysis. No canonical pathways were found to be enriched at a
BH-FDR b 0.1. A top network in IPA was associated with hematological
system development and function and immune cell trafﬁcking. One
networkwas signiﬁcantly correlated with interleukin-1 receptor antag-
onist as upstream regulator.
Secondly, the hypothesis was investigated using likelihood ratio
tests that variability between subjects did not depend on gender and
sampling period (seasonal effect). A set of 25 probes rejected the hy-
pothesis at BH-FDR b 0.05. The probes and their annotation are men-
tioned in a supplementary Excel ﬁle (Supplementary ﬁle 6).
Nine probes from the set of 25 had a variability thatwas different be-
tween the two seasons, of which 4 could be associated to a gene symbol
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Fig. 4. Box plots of the absolute fold changes of the 1995 probes that are called differentially expressed for the factor season. Box plots are constructed for every study participant. The ﬁrst
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35P. De Boever et al. / Genomics 103 (2014) 31–39(TTLL2, HS3ST5, RCC1 and DUSP5P). Only 2 probes (and one that could
be associated to gene symbol HS3ST5) had a variability that was differ-
ent between males and females.
3. Discussion
Human biomonitoring studies are used in the ﬁeld of environ-
mental health to investigate possible associations between lifestyle,
environmental factors and public health. Researchers have adopted
genome-wide transcriptomics analysis of peripheral blood in their
health monitoring studies in order to identify gene expression signa-
tures reﬂecting early biological responses [13]. Such signatures
might also ﬁnd their way as standard research tools if they predict
exposure and/or biological effect in a reliable way [14].
Biomonitoring sampling campaigns are typically spread over a time
period ranging from several weeks to months. Hence, investigators are
uncertain about the impact of this time factor when studying possible
relationships between exposure and gene expression levels in blood.
For example, how much variability can be expected when repeated
measures are performed and howmuch variability is there between in-
dividuals when taking into account factors such as gender and time of
sampling? Also, there may be a long-term (seasonal) effect leading to
differential gene expression. In this context, we have collectedmicroar-
ray data from whole blood samples of non-diseased adult volunteers.
We have assessed gene expression variability within and between indi-
viduals and analyzed if differential gene expression could be detected
within and between seasons.
The variation in gene expression signals in repeated blood samples
of healthy adult individuals has been studied before. These investiga-
tions conclude that gene expression data show a pattern of within-
subject clustering before observing a between-subject clustering
[15–17]. The number of genes that were needed to discriminate be-
tween individuals differs between the studies, but all gene lists were
enriched for interferon stimulation and histocompatibility class genes.
Meaburn and coworkers examined test–retest reliability of geneexpression microarrays and stability of individual differences in blood
samples of ﬁve twin pairs at the age of 12 year [18]. The authors identi-
ﬁed 1752 probes that reliably detected individual differences. They also
found a considerable number of histocompatibility class genes in the
latter probe list. This list was associated with biological functions such
as cell-to-cell signaling and interaction and inﬂammatory disease.
In our study, we observed high pairwise correlations between the
microarray data. The strongest correlationswere observed along the di-
agonal of the heat map and this is indicative for a high within-subject
clustering (Fig. 1). Next, we calculated the between/within sum of
squares ratio (BW ratio) to identify the probes that could discriminate
most between the study participants. An unsupervised clustering per-
formed with 250 probes with the highest BW ratio revealed a perfect
individual-speciﬁc clustering (Fig. 2). A couple of inﬂammatory path-
ways were found to be enriched for this 250 probe list. Comparable to
literature [15–17], we found that genes related to antigen processing
and presentation and inﬂammatory response contributed signiﬁcantly
to the individual-speciﬁc clustering. Additionally, eight probeswere suf-
ﬁcient to obtain a perfect clustering according to gender. Three of those
probes (DDX3Y, KDM5D, and RPS4Y1) also contributed to the gender
clustering in the study of Eady et al. [15].
Repeated measures designs for studying the blood transcriptome
span several weeks [15–17] or several months [18,19]. None of the re-
ported studies explicitly formulated their statistical model in a way
they could assess long-term (seasonal) effects on gene expression. We
studied possible differential gene expression over a period of almost
six months, with a particular focus on within-season and between-
seasons effects. The absence of largewithin-season trends conﬁrms ear-
lier statements on the stability of gene expression signals over short
time periods [15–17].
We formulated a linear mixed-effects model to test the impact of
gender and season on gene expression. The factor season accounted
for differential expression in 1995 probes. GO and pathway analysis
revealed enrichment of general biological terms related to RNAprocess-
ing and protein phosphorylation (Table 3).
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the threshold of statistical signiﬁcance. RhoA signaling is member of the
Ras superfamily of small GTP-binding proteins that play a role in diverse
biological processes such as actin cytoskeleton organization, cell cycle
progression, adhesion and epithelial wound repair. More speciﬁcally,
RhoA dependent signaling pathway is recognized as a regulator of vas-
cular functions [20]. The pathway is also involved in chemokine signal-
ing [21]. Cross-talk of RhoA with immune-related pathways and the
observation that about 10% of the differentially expressed probes
could be associated with viral infection suggest an altered immune sys-
tem reactivity in our study. It is plausible that a challenge of the study
participants with viruses, opportunistic pathogens or allergens was dif-
ferent between the two sampling periods. For example, sampling period
2 occurred in springtime during which higher concentrations of pollen
was recorded. Karlovich and coworkers also observed the impact of
inﬂammatory events on blood gene expression signals in their longitu-
dinal study with healthy volunteers [19].
In formal statistical terms, a probe is differentially expressed if its ex-
pression level changes systematically between two conditions, regard-
less of how small the difference might be. A small difference may be
signiﬁcant (if there is sufﬁcient power due to sufﬁcient number of sam-
ples and small intra-group variation), but it gives no indication about its
biological importance. Ranking genes based on statistical signiﬁcance in
combinationwith the biological effect size (fold change) has been found
to producemoremeaningful gene sets [22,23]. In our study, most of the
1995 differentially expressed probes had fold changes lower than the
liberal 1.3 cutoff value (Fig. 4). Hence, we speculate that the immune
system reactivity observed in our study is a small response.
The expression of 191 probeswas signiﬁcantly affected by gender and
39 of these probes are located on the X or Y chromosome. The expression
of eleven of these probeswas also found to be gender-related in previous
studies: DDX3Y, KDM5D, RPS4Y1, DDX3X, EIF1AX, ZFX, USP9X and
CXorf15 [15], RPS4X, SETP6, RPS4Y and EIF2S3 [17], EIF1AX, EIF2S3 and
RPS4X [19]. The majority of these gender-related probes were also iden-
tiﬁed using the hierarchical clustering procedure (Fig. 2).
We found a large number of probes with signiﬁcant differential
within-subject variability as compared to thosewith signiﬁcant variabilitybetween subjects that depend on gender and/or season. Similar to the
work of Ho and colleagues [24], we may lack sufﬁcient power for detect-
ing differential between- subject variability due to the relative small num-
ber of study participants. It is well-known that within-subject tests for
differential expression are more powerful than between-subject tests,
and this may also be true for the differential variability testing.
For the within-subject variability we could show that the coefﬁcient
of variation was higher in season 2 than in season 1 (Fig. 5). Pathway
analysis of the top-1000 most signiﬁcant probes suggested altered im-
mune system reactivity. Seasonal variation in the activity of immune
cells of mammals is documented [25]. Killestein and co-workers dem-
onstrated that maximum values of TNF-α production by stimulated pe-
ripheral blood mononuclear cells were obtained when cells were
isolated from individuals' blood in autumn [26]. Myrianthefs et al. [27]
showed,when testingwhole blood, that the production of TNF-α during
September was signiﬁcantly lower than that in February and March. In
conclusion, experimental data on animal and human models provide
evidence that the functional activity of immune cells varies in conjunc-
tionwith the period of the year [28]. Hence, we speculate that the larger
coefﬁcients of variation observed in season 2may be related to environ-
mental and climatological conditions.
In conclusion, the results indicate that repeatable data can be obtain-
ed with a high within-subject correlation when analyzing the blood
transcriptome of non-diseased individuals. Probes that could discrimi-
nate between individuals are associated with immune and inﬂammato-
ry functions. When investigating possible time trends in themicroarray
data, we have found no differential expressionwithin a sampling period
(within-season effect). Differential expression was observed between
seasons and the data suggest a weak response of genes related to im-
mune system functioning. Finally, a high number of probes showed
signiﬁcant season-speciﬁc expression variability within subjects. Ex-
pression variability increased in springtime and the probe list could be
associated with immune system functioning.
The strength of our study is that we have set up a repeated mea-
sures design in a homogenous panel of non-diseased adults, hence
reducing potential confounding.We have usedmixed-effects models
to analyze the impact of gender, short-term and long-term time
37P. De Boever et al. / Genomics 103 (2014) 31–39effects on gene expression signals. The different sources of variability
in our experiment are collected in a random effects parameter under
parametric assumptions. A criticism may be that our sample size is
too small for detecting genuine signiﬁcant effects using such as-
sumptions. Non-parametric analyses using bootstrapping tech-
niques and sandwich estimators could provide an alternative
[29,30]. However, our dataset is small to detect signiﬁcant changes
using these methods. We are convinced that our model reﬂects ade-
quately the association structure of the experiment. Furthermore, it
has been shown that linear mixed-effects models with parametric
assumptions are robust for model misspeciﬁcations [31].
This study was set up to analyze genome-wide gene expression sig-
nals. The results have not been validated with other molecular biology
methods. However, we have used Agilent microarray technology and
associated protocols that have been proven to be reproducible and in
good agreement with other microarray platforms and real-time PCR
[32–34].
Our study suggests that the blood transcriptome of healthy individ-
uals is reproducible over a time period of several months. One can con-
template that our ﬁndings may not be representative for the whole
population. Subsequent research should therefore aim at conﬁrming
the observations in larger study groups, different age groups and sus-
ceptible populations. For example, one can expect that individuals
with underlying (chronic) inﬂammation may have higher variability
in gene expression than the healthy adults tested in our study. Underly-
ing seasonal differences may have contributed to the observed differen-
tial expression and expression variability in our study. Future research
could focus on identifying the variables that are the most relevant.
Also, one could investigatewhat the impact is of more extremeweather
conditions by comparing gene expression proﬁles from winter and
summer sampling campaigns.
With our study we wanted to contribute to the speciﬁcation of the
blood transcriptome in a sample of the general population. The identiﬁ-
cation of gender-related and season-related effects is important in the
context of molecular epidemiology. Analysis of expression variability
is useful for estimating sample sizes required to achieve a certain
power to detect changes in gene expression of a particular magnitude.
Hence, our data can be valuable for the design and conduct of future
human biomonitoring studies that want to test the biological impact
of environmental stressors and employ gene expression as an
assessment.4. Materials and methods
4.1. Experimental set-up
The study was conducted between November 2009 and May 2010
and included employees of the Flemish Institute for Technological
Research (VITO), Belgium. Participants were 24 to 39 years old and
free of clinically diagnosed diseases before and during the study period.
The individuals donated 3-mL blood samples during three consecutive
weeks in the year 2009 (weeks 46, 47 and 48) and three samples in
the year 2010 (weeks 17, 18 and 19). The ﬁrst sampling period was in
the autumn of the year 2009 and is referred to as season 1, whereas
sampling period 2 was in the spring of the year 2010 and is called sea-
son 2. Non-fasting blood was collected by phlebotomy in Tempus
Blood RNA tubes (Life Technologies, Halle, Belgium) between 8 am
and 12 pm at the medical department of the Belgian Nuclear Research
Centre, which is situated on the same site as VITO. The content of the
tubes was immediately mixed and samples were frozen at −20 °C
within 1 h after collection. On each study day, the persons completed
a short questionnaire to obtain information on medical history, use of
medication and lifestyle aspects. The study was approved by the ethics
committee of the Antwerp University (UA A09 21). All subjects gave
written informed consent to participate.4.2. Environmental conditions
4.2.1. Outdoor temperature
Information on outdoor temperature were obtained from the
Belgian Nuclear Research Centre. An average daily temperature was
calculated for the 2 study periods (season 1 and season 2).
4.2.2. Air pollution levels
Ambient air pollution levels were measured at a nearby ofﬁcial
monitoring station in Dessel and were obtained from the Flemish Envi-
ronment Agency. The distance from Dessel to the VITO campus is be-
tween 5 and 9 km. The station monitors every half hour the ambient
concentrations of a range of air pollutants. Concentrations aremeasured
using beta absorption technique (PM10), chemoluminescence (NO and
NO2), UV ﬂuorescence (SO2) and UV spectrophotometry (O3). Average
daily concentrationswere calculated and are expressed in μg/m3. An av-
erage concentration was calculated for each pollutant for the 2 study
periods.
Concentrations of pollen and spores were measured at an ofﬁcial
monitoring station in Antwerp and were obtained from the Service of
Mycology and Aerobiology of the Scientiﬁc Institute of Public Health.
The distance from Antwerp to the VITO campus is between 25 and
30 km. The station collects pollen and fungal spores with a Burkard Vol-
umetric Spore Sampler unit. Air is captured on a prepared adhesive tape
at a set rate corresponding to the human respiration rate (10 l per min-
ute). Counts and identiﬁcations are done microscopically for an area
that is representative of 1 cubic meter of air per day. Average daily con-
centrationswere calculated and are expressed in counts/m3. An average
concentration was calculated for each pollutant for the 2 study periods.
4.3. RNA processing and quantiﬁcation
Total RNAwas extracted using the Tempus Spin RNA Isolation kit ac-
cording to the manufacturer's instructions (Life Technologies). RNA
yields were checked using the NanoDrop Spectrophotometer (Isogen
Life Science, PWDeMeern, the Netherlands). GlobinmRNAwas deplet-
ed from total RNA preparations according to the instructions provided
with the Ambion Globinclear kit (Life Technologies).
The integrity of the remaining globin-depleted RNAwas determined
with the Agilent 2100 Bioanalyzer using RNA 6000 Chips (Agilent Tech-
nologies, Diegem, Belgium). Samples were stored at−80 °C.
4.4. RNA ampliﬁcation and labeling
The globin-depleted RNA was ampliﬁed and labeled to generate
complementary RNA (cRNA) using the Low Input Quick Amp Labeling
(one color) kit from Agilent Technologies. An aliquot of 100–200 ng of
RNA was reverse transcribed into complementary DNA (cDNA) using
T7-promotor primer and MMLV reverse transcriptase. The cDNA was
transcribed into cRNA with a simultaneous incorporation of cyanine 3-
CTP (Cy3). The single-stranded, labeled cRNA was puriﬁed with
Qiagen's RNeasy mini spin columns (Qiagen, KJ Venlo, Netherlands).
Yield and speciﬁc activity were determined using the NanoDrop
spectrophotometer.
4.5. Microarray analysis and data preprocessing
Aliquots of 1.65 μg cRNA were hybridized on 4x44K Agilent Whole
Human Genome microarray slides (design 014850) for 17 h using the
automated HS4800TM pro hybridization station according to the
manufacturer's instructions (Tecan, Männedorf, Switzerland). The ar-
rays were scanned on an Agilent DNA microarray scanner (G2565BA)
and processed using Agilent Feature Extraction Software (Version
10.5). The Agilent protocol GE1-10.7-SEP09 was used to convert the
scanned tiff images to text ﬁles. The gProcessedSignal per probe was
used for the analysis. The latter signals were quantile normalized and
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gies). Probes that were replicated on the arraywere reported asmedian
signals. The control probes were removed and data ﬁles with the ex-
pression signals of 41,000 unique probes were obtained. Data was fur-
ther ﬁltered using local background correction, ﬂagging of bad spots,
controls and spots with too low intensity [35].
4.6. Descriptive statistics
Pairwise Spearman correlations were calculated to evaluate the re-
latedness of the microarray gene expression proﬁles. The between/
within sumof squares (BW) ratio across the 22 individualswas calculat-
ed for each probe using the method of Dudoit and coworkers [35]. This
allows identifying the microarray probes that are able to discriminate
between the individuals. A subset of 250 probes with the highest BW
ratio was used for hierarchical cluster analysis. The latter procedure
was performed on the normalized gene expression signals of the 250
probes. Hierarchical clustering of samples and probes was performed
using the Pearson correlation coefﬁcient and the average linkage proce-
dure [36]. Finally, we calculated for the 22 individuals the coefﬁcient of
variation for every probe signal. The coefﬁcient of variation was based
on six samples per person. A cumulative distribution of this intra-
individual coefﬁcient of variation was plotted. Descriptive statistics
have been performed in MATLAB R2013a (The Mathworks Inc., Natick,
MA).
4.7. Statistical analysis of time trends
Identiﬁcation of time trends was done using linear mixed-effects
models. This was performed with the SAS Procedure MIXED for each
probe using log2-transformed expression values (SAS® version 9.2,
SAS Institute Inc., Cary, NC). Correction for multiplicity was done using
the Benjamini–Hochberg false discovery rate correction (BH-FDR)
using themulttest package in R 2.15 [37]. A probe was called signiﬁcant
when its BH-FDR b 0.05.
Short-term time effects were assessed by using the three repeated
measures obtained per subject. This within-season analysis was per-
formed for both sampling periods. The linear mixed-effects model can
be formulated as follows (model 1):
Yigt ¼ β0 þ β1dit þαg þ bi þ εigt: ð1Þ
Yigt is the normalized and log2-tranformed signal intensity for sub-
ject i (i = 1,2,…, 22), gender g (g = 1,2), measured at time point t
(t = 1,2,3), β0 is the overall mean,β1 is the slope estimate for the linear
time point effect,αg represents the effect of the gender, bi is subject i ef-
fect, and εigt represents the random error of subject i gender g and time
point t. β0, β1 and αg are ﬁxed effects while bi is a random effect as-
sumed to have mean zero and variance σb2. εigt is assumed to have
mean zero and variance σε2.
The observations within one season were also considered as repeat-
edmeasures and the effect of season, gender, and their interaction term
on gene expression were assessed. This linear mixed-effects model 2 is
given by:
Yigst ¼ β0 þ τs þ αg þ ταð Þsg þ bi þ bτð Þis þ εigst: ð2Þ
Yigst is the normalized and log2-tranformed signal intensity for sub-
ject i, gender g, measured at time point t in season s, β0 is the overall
mean, τs equals the effect of season, αg represents the effect of gender,
(τα)sg is a season by gender interaction effect. Furthermore, bi is the
overall effect of subject i, (b,τ)is is the subject by season interaction,
and εigst represents the random error of subject i, gender g, season s,
and time point t. The parameters β0, τs, αg and (τα)sg are ﬁxed effects,
while bi, (bτ)is and εigst are subject-speciﬁc random effects assumed to
be normally distributed with mean zero.Probes that were called signiﬁcant for the factor season in model 2
were selected for calculating a biological change (fold change). This
was done for each individual by taking the ratio of the average of the re-
peated measurements in the 2 seasons.
Box plots of the fold changes of the probes called signiﬁcant for the
ﬁxed effect season were plotted for each individual using the ggplot2
package in R 2.15 [38].
4.8. Analysis of gender- and season-speciﬁc variability
The variance–covariance structure ofmodel 2 was used to formulate
hypotheses about the variance components of that model. First, it was
tested if within-subject variability depends on gender and/or sampling
period (seasonal effect). Secondly, it was investigated if variability be-
tween subjects depends on gender and/or sampling period (seasonal ef-
fect). These hypotheses were evaluated for each probe using likelihood
ratio tests [39]. All p-values were corrected for multiplicity. Density
plots of the coefﬁcients of variation were generated for probes that
rejected the null hypothesis. In order to reduce the number of non-
informative probes in the plots, all probes without an associated gene
symbol and with a coefﬁcient of variation lower that 5% were eliminat-
ed. Plots were generated using the ggplot2 package.
4.9. Biological interpretation
GeneSpring was used as a primary entry point for the biological in-
terpretation of themicroarray data. Probes weremapped to their corre-
sponding gene symbol. Gene Ontology (GO) analysis was performed
with a BH-FDR set at 0.1. Biological interpretation was also done with
Ingenuity Pathway Analysis (IPA build 220217, Ingenuity® Systems,
http://www.ingenuity.com). Canonical pathway analysis identiﬁed the
pathways from the IPA library of canonical pathways that were most
signiﬁcant to the dataset. The signiﬁcance of the association between
the dataset and the canonical pathway was measured with a Fisher's
exact test with p-values being corrected using BH-FDR. The threshold
was set at 0.1.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.ygeno.2013.11.006.
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